0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global E. coli Competent Cells Market Research Report 2024
Published Date: December 2024
|
Report Code: QYRE-Auto-2N18854
Home | Market Reports | Science| Biological Sciences
Global E coli Competent Cells Market Research Report 2024
BUY CHAPTERS

Global E. coli Competent Cells Market Research Report 2024

Code: QYRE-Auto-2N18854
Report
December 2024
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

E. coli Competent Cells Market Size

The global market for E. coli Competent Cells was valued at US$ 796 million in the year 2023 and is projected to reach a revised size of US$ 1293 million by 2030, growing at a CAGR of 7.5% during the forecast period.

E. coli Competent Cells Market

E. coli Competent Cells Market

E. coli Competent Cells are strains of Escherichia coli that have been treated to increase their ability to take up foreign DNA through a process called transformation. This makes them indispensable tools in molecular biology for applications like cloning, plasmid propagation, and genetic engineering.
North American market for E. coli Competent Cells is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for E. coli Competent Cells is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of E. coli Competent Cells include Merck, Thermo Fisher Scientific, Takara Bio, Agilent, Beijing TransGen Biotech, New England Biolabs (NEB), Promega Corporation, GenScript, New England Biolabs, Bio-Rad, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for E. coli Competent Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding E. coli Competent Cells.
The E. coli Competent Cells market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global E. coli Competent Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the E. coli Competent Cells manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of E. coli Competent Cells Market Report

Report Metric Details
Report Name E. coli Competent Cells Market
Accounted market size in year US$ 796 million
Forecasted market size in 2030 US$ 1293 million
CAGR 7.5%
Base Year year
Forecasted years 2024 - 2030
Segment by Type
Segment by Application
  • Cloning
  • Proteomics
  • Genomics
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Thermo Fisher Scientific, Takara Bio, Agilent, Beijing TransGen Biotech, New England Biolabs (NEB), Promega Corporation, GenScript, New England Biolabs, Bio-Rad, Bioline, IBA, QIAGEN, LGC Biosearch Technologies, Addgene, Zymo Research, Scarab Genomics, GCC Biotech, NCM Biotech, Beyotime, Yeasen, TIANGEN, Maokangbio, ZOMANBIO
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of E. coli Competent Cells manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of E. coli Competent Cells in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is E. coli Competent Cells Market growing?

Ans: The E. coli Competent Cells Market witnessing a CAGR of 7.5% during the forecast period 2024-2030.

What is the E. coli Competent Cells Market size in 2030?

Ans: The E. coli Competent Cells Market size in 2030 will be US$ 1293 million.

Who are the main players in the E. coli Competent Cells Market report?

Ans: The main players in the E. coli Competent Cells Market are Merck, Thermo Fisher Scientific, Takara Bio, Agilent, Beijing TransGen Biotech, New England Biolabs (NEB), Promega Corporation, GenScript, New England Biolabs, Bio-Rad, Bioline, IBA, QIAGEN, LGC Biosearch Technologies, Addgene, Zymo Research, Scarab Genomics, GCC Biotech, NCM Biotech, Beyotime, Yeasen, TIANGEN, Maokangbio, ZOMANBIO

What are the Application segmentation covered in the E. coli Competent Cells Market report?

Ans: The Applications covered in the E. coli Competent Cells Market report are Cloning, Proteomics, Genomics

What are the Type segmentation covered in the E. coli Competent Cells Market report?

Ans: The Types covered in the E. coli Competent Cells Market report are Chemically Competent Cells, Electrocompetent Cells

Recommended Reports

Cell Culture & Processing

Cell-Based Foods

Cell Therapy & Analysis

1 E. coli Competent Cells Market Overview
1.1 Product Definition
1.2 E. coli Competent Cells by Type
1.2.1 Global E. coli Competent Cells Market Value Comparison by Type (2024-2030)
1.2.2 Chemically Competent Cells
1.2.3 Electrocompetent Cells
1.3 E. coli Competent Cells by Application
1.3.1 Global E. coli Competent Cells Market Value by Application (2024-2030)
1.3.2 Cloning
1.3.3 Proteomics
1.3.4 Genomics
1.4 Global E. coli Competent Cells Market Size Estimates and Forecasts
1.4.1 Global E. coli Competent Cells Revenue 2019-2030
1.4.2 Global E. coli Competent Cells Sales 2019-2030
1.4.3 Global E. coli Competent Cells Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 E. coli Competent Cells Market Competition by Manufacturers
2.1 Global E. coli Competent Cells Sales Market Share by Manufacturers (2019-2024)
2.2 Global E. coli Competent Cells Revenue Market Share by Manufacturers (2019-2024)
2.3 Global E. coli Competent Cells Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of E. coli Competent Cells, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of E. coli Competent Cells, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of E. coli Competent Cells, Product Type & Application
2.7 Global Key Manufacturers of E. coli Competent Cells, Date of Enter into This Industry
2.8 Global E. coli Competent Cells Market Competitive Situation and Trends
2.8.1 Global E. coli Competent Cells Market Concentration Rate
2.8.2 The Global 5 and 10 Largest E. coli Competent Cells Players Market Share by Revenue
2.8.3 Global E. coli Competent Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global E. coli Competent Cells Market Scenario by Region
3.1 Global E. coli Competent Cells Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global E. coli Competent Cells Sales by Region: 2019-2030
3.2.1 Global E. coli Competent Cells Sales by Region: 2019-2024
3.2.2 Global E. coli Competent Cells Sales by Region: 2025-2030
3.3 Global E. coli Competent Cells Revenue by Region: 2019-2030
3.3.1 Global E. coli Competent Cells Revenue by Region: 2019-2024
3.3.2 Global E. coli Competent Cells Revenue by Region: 2025-2030
3.4 North America E. coli Competent Cells Market Facts & Figures by Country
3.4.1 North America E. coli Competent Cells Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America E. coli Competent Cells Sales by Country (2019-2030)
3.4.3 North America E. coli Competent Cells Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe E. coli Competent Cells Market Facts & Figures by Country
3.5.1 Europe E. coli Competent Cells Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe E. coli Competent Cells Sales by Country (2019-2030)
3.5.3 Europe E. coli Competent Cells Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific E. coli Competent Cells Market Facts & Figures by Region
3.6.1 Asia Pacific E. coli Competent Cells Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific E. coli Competent Cells Sales by Region (2019-2030)
3.6.3 Asia Pacific E. coli Competent Cells Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America E. coli Competent Cells Market Facts & Figures by Country
3.7.1 Latin America E. coli Competent Cells Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America E. coli Competent Cells Sales by Country (2019-2030)
3.7.3 Latin America E. coli Competent Cells Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa E. coli Competent Cells Market Facts & Figures by Country
3.8.1 Middle East and Africa E. coli Competent Cells Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa E. coli Competent Cells Sales by Country (2019-2030)
3.8.3 Middle East and Africa E. coli Competent Cells Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global E. coli Competent Cells Sales by Type (2019-2030)
4.1.1 Global E. coli Competent Cells Sales by Type (2019-2024)
4.1.2 Global E. coli Competent Cells Sales by Type (2025-2030)
4.1.3 Global E. coli Competent Cells Sales Market Share by Type (2019-2030)
4.2 Global E. coli Competent Cells Revenue by Type (2019-2030)
4.2.1 Global E. coli Competent Cells Revenue by Type (2019-2024)
4.2.2 Global E. coli Competent Cells Revenue by Type (2025-2030)
4.2.3 Global E. coli Competent Cells Revenue Market Share by Type (2019-2030)
4.3 Global E. coli Competent Cells Price by Type (2019-2030)
5 Segment by Application
5.1 Global E. coli Competent Cells Sales by Application (2019-2030)
5.1.1 Global E. coli Competent Cells Sales by Application (2019-2024)
5.1.2 Global E. coli Competent Cells Sales by Application (2025-2030)
5.1.3 Global E. coli Competent Cells Sales Market Share by Application (2019-2030)
5.2 Global E. coli Competent Cells Revenue by Application (2019-2030)
5.2.1 Global E. coli Competent Cells Revenue by Application (2019-2024)
5.2.2 Global E. coli Competent Cells Revenue by Application (2025-2030)
5.2.3 Global E. coli Competent Cells Revenue Market Share by Application (2019-2030)
5.3 Global E. coli Competent Cells Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck E. coli Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck E. coli Competent Cells Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Company Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific E. coli Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Thermo Fisher Scientific E. coli Competent Cells Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 Takara Bio
6.3.1 Takara Bio Company Information
6.3.2 Takara Bio Description and Business Overview
6.3.3 Takara Bio E. coli Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Takara Bio E. coli Competent Cells Product Portfolio
6.3.5 Takara Bio Recent Developments/Updates
6.4 Agilent
6.4.1 Agilent Company Information
6.4.2 Agilent Description and Business Overview
6.4.3 Agilent E. coli Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Agilent E. coli Competent Cells Product Portfolio
6.4.5 Agilent Recent Developments/Updates
6.5 Beijing TransGen Biotech
6.5.1 Beijing TransGen Biotech Company Information
6.5.2 Beijing TransGen Biotech Description and Business Overview
6.5.3 Beijing TransGen Biotech E. coli Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Beijing TransGen Biotech E. coli Competent Cells Product Portfolio
6.5.5 Beijing TransGen Biotech Recent Developments/Updates
6.6 New England Biolabs (NEB)
6.6.1 New England Biolabs (NEB) Company Information
6.6.2 New England Biolabs (NEB) Description and Business Overview
6.6.3 New England Biolabs (NEB) E. coli Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.6.4 New England Biolabs (NEB) E. coli Competent Cells Product Portfolio
6.6.5 New England Biolabs (NEB) Recent Developments/Updates
6.7 Promega Corporation
6.7.1 Promega Corporation Company Information
6.7.2 Promega Corporation Description and Business Overview
6.7.3 Promega Corporation E. coli Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Promega Corporation E. coli Competent Cells Product Portfolio
6.7.5 Promega Corporation Recent Developments/Updates
6.8 GenScript
6.8.1 GenScript Company Information
6.8.2 GenScript Description and Business Overview
6.8.3 GenScript E. coli Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.8.4 GenScript E. coli Competent Cells Product Portfolio
6.8.5 GenScript Recent Developments/Updates
6.9 New England Biolabs
6.9.1 New England Biolabs Company Information
6.9.2 New England Biolabs Description and Business Overview
6.9.3 New England Biolabs E. coli Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.9.4 New England Biolabs E. coli Competent Cells Product Portfolio
6.9.5 New England Biolabs Recent Developments/Updates
6.10 Bio-Rad
6.10.1 Bio-Rad Company Information
6.10.2 Bio-Rad Description and Business Overview
6.10.3 Bio-Rad E. coli Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bio-Rad E. coli Competent Cells Product Portfolio
6.10.5 Bio-Rad Recent Developments/Updates
6.11 Bioline
6.11.1 Bioline Company Information
6.11.2 Bioline Description and Business Overview
6.11.3 Bioline E. coli Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Bioline E. coli Competent Cells Product Portfolio
6.11.5 Bioline Recent Developments/Updates
6.12 IBA
6.12.1 IBA Company Information
6.12.2 IBA Description and Business Overview
6.12.3 IBA E. coli Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.12.4 IBA E. coli Competent Cells Product Portfolio
6.12.5 IBA Recent Developments/Updates
6.13 QIAGEN
6.13.1 QIAGEN Company Information
6.13.2 QIAGEN Description and Business Overview
6.13.3 QIAGEN E. coli Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.13.4 QIAGEN E. coli Competent Cells Product Portfolio
6.13.5 QIAGEN Recent Developments/Updates
6.14 LGC Biosearch Technologies
6.14.1 LGC Biosearch Technologies Company Information
6.14.2 LGC Biosearch Technologies Description and Business Overview
6.14.3 LGC Biosearch Technologies E. coli Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.14.4 LGC Biosearch Technologies E. coli Competent Cells Product Portfolio
6.14.5 LGC Biosearch Technologies Recent Developments/Updates
6.15 Addgene
6.15.1 Addgene Company Information
6.15.2 Addgene Description and Business Overview
6.15.3 Addgene E. coli Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Addgene E. coli Competent Cells Product Portfolio
6.15.5 Addgene Recent Developments/Updates
6.16 Zymo Research
6.16.1 Zymo Research Company Information
6.16.2 Zymo Research Description and Business Overview
6.16.3 Zymo Research E. coli Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Zymo Research E. coli Competent Cells Product Portfolio
6.16.5 Zymo Research Recent Developments/Updates
6.17 Scarab Genomics
6.17.1 Scarab Genomics Company Information
6.17.2 Scarab Genomics Description and Business Overview
6.17.3 Scarab Genomics E. coli Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Scarab Genomics E. coli Competent Cells Product Portfolio
6.17.5 Scarab Genomics Recent Developments/Updates
6.18 GCC Biotech
6.18.1 GCC Biotech Company Information
6.18.2 GCC Biotech Description and Business Overview
6.18.3 GCC Biotech E. coli Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.18.4 GCC Biotech E. coli Competent Cells Product Portfolio
6.18.5 GCC Biotech Recent Developments/Updates
6.19 NCM Biotech
6.19.1 NCM Biotech Company Information
6.19.2 NCM Biotech Description and Business Overview
6.19.3 NCM Biotech E. coli Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.19.4 NCM Biotech E. coli Competent Cells Product Portfolio
6.19.5 NCM Biotech Recent Developments/Updates
6.20 Beyotime
6.20.1 Beyotime Company Information
6.20.2 Beyotime Description and Business Overview
6.20.3 Beyotime E. coli Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Beyotime E. coli Competent Cells Product Portfolio
6.20.5 Beyotime Recent Developments/Updates
6.21 Yeasen
6.21.1 Yeasen Company Information
6.21.2 Yeasen Description and Business Overview
6.21.3 Yeasen E. coli Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Yeasen E. coli Competent Cells Product Portfolio
6.21.5 Yeasen Recent Developments/Updates
6.22 TIANGEN
6.22.1 TIANGEN Company Information
6.22.2 TIANGEN Description and Business Overview
6.22.3 TIANGEN E. coli Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.22.4 TIANGEN E. coli Competent Cells Product Portfolio
6.22.5 TIANGEN Recent Developments/Updates
6.23 Maokangbio
6.23.1 Maokangbio Company Information
6.23.2 Maokangbio Description and Business Overview
6.23.3 Maokangbio E. coli Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Maokangbio E. coli Competent Cells Product Portfolio
6.23.5 Maokangbio Recent Developments/Updates
6.24 ZOMANBIO
6.24.1 ZOMANBIO Company Information
6.24.2 ZOMANBIO Description and Business Overview
6.24.3 ZOMANBIO E. coli Competent Cells Sales, Revenue and Gross Margin (2019-2024)
6.24.4 ZOMANBIO E. coli Competent Cells Product Portfolio
6.24.5 ZOMANBIO Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 E. coli Competent Cells Industry Chain Analysis
7.2 E. coli Competent Cells Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 E. coli Competent Cells Production Mode & Process
7.4 E. coli Competent Cells Sales and Marketing
7.4.1 E. coli Competent Cells Sales Channels
7.4.2 E. coli Competent Cells Distributors
7.5 E. coli Competent Cells Customers
8 E. coli Competent Cells Market Dynamics
8.1 E. coli Competent Cells Industry Trends
8.2 E. coli Competent Cells Market Drivers
8.3 E. coli Competent Cells Market Challenges
8.4 E. coli Competent Cells Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global E. coli Competent Cells Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global E. coli Competent Cells Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global E. coli Competent Cells Market Competitive Situation by Manufacturers in 2023
 Table 4. Global E. coli Competent Cells Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global E. coli Competent Cells Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global E. coli Competent Cells Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global E. coli Competent Cells Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market E. coli Competent Cells Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of E. coli Competent Cells, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of E. coli Competent Cells, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of E. coli Competent Cells, Product Type & Application
 Table 12. Global Key Manufacturers of E. coli Competent Cells, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global E. coli Competent Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in E. coli Competent Cells as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global E. coli Competent Cells Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global E. coli Competent Cells Sales by Region (2019-2024) & (K Units)
 Table 18. Global E. coli Competent Cells Sales Market Share by Region (2019-2024)
 Table 19. Global E. coli Competent Cells Sales by Region (2025-2030) & (K Units)
 Table 20. Global E. coli Competent Cells Sales Market Share by Region (2025-2030)
 Table 21. Global E. coli Competent Cells Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global E. coli Competent Cells Revenue Market Share by Region (2019-2024)
 Table 23. Global E. coli Competent Cells Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global E. coli Competent Cells Revenue Market Share by Region (2025-2030)
 Table 25. North America E. coli Competent Cells Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America E. coli Competent Cells Sales by Country (2019-2024) & (K Units)
 Table 27. North America E. coli Competent Cells Sales by Country (2025-2030) & (K Units)
 Table 28. North America E. coli Competent Cells Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America E. coli Competent Cells Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe E. coli Competent Cells Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe E. coli Competent Cells Sales by Country (2019-2024) & (K Units)
 Table 32. Europe E. coli Competent Cells Sales by Country (2025-2030) & (K Units)
 Table 33. Europe E. coli Competent Cells Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe E. coli Competent Cells Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific E. coli Competent Cells Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific E. coli Competent Cells Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific E. coli Competent Cells Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific E. coli Competent Cells Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific E. coli Competent Cells Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America E. coli Competent Cells Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America E. coli Competent Cells Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America E. coli Competent Cells Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America E. coli Competent Cells Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America E. coli Competent Cells Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa E. coli Competent Cells Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa E. coli Competent Cells Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa E. coli Competent Cells Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa E. coli Competent Cells Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa E. coli Competent Cells Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global E. coli Competent Cells Sales (K Units) by Type (2019-2024)
 Table 51. Global E. coli Competent Cells Sales (K Units) by Type (2025-2030)
 Table 52. Global E. coli Competent Cells Sales Market Share by Type (2019-2024)
 Table 53. Global E. coli Competent Cells Sales Market Share by Type (2025-2030)
 Table 54. Global E. coli Competent Cells Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global E. coli Competent Cells Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global E. coli Competent Cells Revenue Market Share by Type (2019-2024)
 Table 57. Global E. coli Competent Cells Revenue Market Share by Type (2025-2030)
 Table 58. Global E. coli Competent Cells Price (US$/Unit) by Type (2019-2024)
 Table 59. Global E. coli Competent Cells Price (US$/Unit) by Type (2025-2030)
 Table 60. Global E. coli Competent Cells Sales (K Units) by Application (2019-2024)
 Table 61. Global E. coli Competent Cells Sales (K Units) by Application (2025-2030)
 Table 62. Global E. coli Competent Cells Sales Market Share by Application (2019-2024)
 Table 63. Global E. coli Competent Cells Sales Market Share by Application (2025-2030)
 Table 64. Global E. coli Competent Cells Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global E. coli Competent Cells Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global E. coli Competent Cells Revenue Market Share by Application (2019-2024)
 Table 67. Global E. coli Competent Cells Revenue Market Share by Application (2025-2030)
 Table 68. Global E. coli Competent Cells Price (US$/Unit) by Application (2019-2024)
 Table 69. Global E. coli Competent Cells Price (US$/Unit) by Application (2025-2030)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Merck E. coli Competent Cells Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Thermo Fisher Scientific Company Information
 Table 76. Thermo Fisher Scientific Description and Business Overview
 Table 77. Thermo Fisher Scientific E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Thermo Fisher Scientific E. coli Competent Cells Product
 Table 79. Thermo Fisher Scientific Recent Developments/Updates
 Table 80. Takara Bio Company Information
 Table 81. Takara Bio Description and Business Overview
 Table 82. Takara Bio E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Takara Bio E. coli Competent Cells Product
 Table 84. Takara Bio Recent Developments/Updates
 Table 85. Agilent Company Information
 Table 86. Agilent Description and Business Overview
 Table 87. Agilent E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Agilent E. coli Competent Cells Product
 Table 89. Agilent Recent Developments/Updates
 Table 90. Beijing TransGen Biotech Company Information
 Table 91. Beijing TransGen Biotech Description and Business Overview
 Table 92. Beijing TransGen Biotech E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Beijing TransGen Biotech E. coli Competent Cells Product
 Table 94. Beijing TransGen Biotech Recent Developments/Updates
 Table 95. New England Biolabs (NEB) Company Information
 Table 96. New England Biolabs (NEB) Description and Business Overview
 Table 97. New England Biolabs (NEB) E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. New England Biolabs (NEB) E. coli Competent Cells Product
 Table 99. New England Biolabs (NEB) Recent Developments/Updates
 Table 100. Promega Corporation Company Information
 Table 101. Promega Corporation Description and Business Overview
 Table 102. Promega Corporation E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Promega Corporation E. coli Competent Cells Product
 Table 104. Promega Corporation Recent Developments/Updates
 Table 105. GenScript Company Information
 Table 106. GenScript Description and Business Overview
 Table 107. GenScript E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. GenScript E. coli Competent Cells Product
 Table 109. GenScript Recent Developments/Updates
 Table 110. New England Biolabs Company Information
 Table 111. New England Biolabs Description and Business Overview
 Table 112. New England Biolabs E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. New England Biolabs E. coli Competent Cells Product
 Table 114. New England Biolabs Recent Developments/Updates
 Table 115. Bio-Rad Company Information
 Table 116. Bio-Rad Description and Business Overview
 Table 117. Bio-Rad E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Bio-Rad E. coli Competent Cells Product
 Table 119. Bio-Rad Recent Developments/Updates
 Table 120. Bioline Company Information
 Table 121. Bioline Description and Business Overview
 Table 122. Bioline E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Bioline E. coli Competent Cells Product
 Table 124. Bioline Recent Developments/Updates
 Table 125. IBA Company Information
 Table 126. IBA Description and Business Overview
 Table 127. IBA E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. IBA E. coli Competent Cells Product
 Table 129. IBA Recent Developments/Updates
 Table 130. QIAGEN Company Information
 Table 131. QIAGEN Description and Business Overview
 Table 132. QIAGEN E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. QIAGEN E. coli Competent Cells Product
 Table 134. QIAGEN Recent Developments/Updates
 Table 135. LGC Biosearch Technologies Company Information
 Table 136. LGC Biosearch Technologies Description and Business Overview
 Table 137. LGC Biosearch Technologies E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. LGC Biosearch Technologies E. coli Competent Cells Product
 Table 139. LGC Biosearch Technologies Recent Developments/Updates
 Table 140. Addgene Company Information
 Table 141. Addgene Description and Business Overview
 Table 142. Addgene E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. Addgene E. coli Competent Cells Product
 Table 144. Addgene Recent Developments/Updates
 Table 145. Zymo Research Company Information
 Table 146. Zymo Research Description and Business Overview
 Table 147. Zymo Research E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 148. Zymo Research E. coli Competent Cells Product
 Table 149. Zymo Research Recent Developments/Updates
 Table 150. Scarab Genomics Company Information
 Table 151. Scarab Genomics Description and Business Overview
 Table 152. Scarab Genomics E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 153. Scarab Genomics E. coli Competent Cells Product
 Table 154. Scarab Genomics Recent Developments/Updates
 Table 155. GCC Biotech Company Information
 Table 156. GCC Biotech Description and Business Overview
 Table 157. GCC Biotech E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 158. GCC Biotech E. coli Competent Cells Product
 Table 159. GCC Biotech Recent Developments/Updates
 Table 160. NCM Biotech Company Information
 Table 161. NCM Biotech Description and Business Overview
 Table 162. NCM Biotech E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 163. NCM Biotech E. coli Competent Cells Product
 Table 164. NCM Biotech Recent Developments/Updates
 Table 165. Beyotime Company Information
 Table 166. Beyotime Description and Business Overview
 Table 167. Beyotime E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 168. Beyotime E. coli Competent Cells Product
 Table 169. Beyotime Recent Developments/Updates
 Table 170. Yeasen Company Information
 Table 171. Yeasen Description and Business Overview
 Table 172. Yeasen E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 173. Yeasen E. coli Competent Cells Product
 Table 174. Yeasen Recent Developments/Updates
 Table 175. TIANGEN Company Information
 Table 176. TIANGEN Description and Business Overview
 Table 177. TIANGEN E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 178. TIANGEN E. coli Competent Cells Product
 Table 179. TIANGEN Recent Developments/Updates
 Table 180. Maokangbio Company Information
 Table 181. Maokangbio Description and Business Overview
 Table 182. Maokangbio E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 183. Maokangbio E. coli Competent Cells Product
 Table 184. Maokangbio Recent Developments/Updates
 Table 185. ZOMANBIO Company Information
 Table 186. ZOMANBIO Description and Business Overview
 Table 187. ZOMANBIO E. coli Competent Cells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 188. ZOMANBIO E. coli Competent Cells Product
 Table 189. ZOMANBIO Recent Developments/Updates
 Table 190. Key Raw Materials Lists
 Table 191. Raw Materials Key Suppliers Lists
 Table 192. E. coli Competent Cells Distributors List
 Table 193. E. coli Competent Cells Customers List
 Table 194. E. coli Competent Cells Market Trends
 Table 195. E. coli Competent Cells Market Drivers
 Table 196. E. coli Competent Cells Market Challenges
 Table 197. E. coli Competent Cells Market Restraints
 Table 198. Research Programs/Design for This Report
 Table 199. Key Data Information from Secondary Sources
 Table 200. Key Data Information from Primary Sources
 Table 201. Authors List of This Report


List of Figures
 Figure 1. Product Picture of E. coli Competent Cells
 Figure 2. Global E. coli Competent Cells Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global E. coli Competent Cells Market Share by Type: 2023 & 2030
 Figure 4. Chemically Competent Cells Product Picture
 Figure 5. Electrocompetent Cells Product Picture
 Figure 6. Global E. coli Competent Cells Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global E. coli Competent Cells Market Share by Application: 2023 & 2030
 Figure 8. Cloning
 Figure 9. Proteomics
 Figure 10. Genomics
 Figure 11. Global E. coli Competent Cells Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global E. coli Competent Cells Market Size (2019-2030) & (US$ Million)
 Figure 13. Global E. coli Competent Cells Sales (2019-2030) & (K Units)
 Figure 14. Global E. coli Competent Cells Average Price (US$/Unit) & (2019-2030)
 Figure 15. E. coli Competent Cells Report Years Considered
 Figure 16. E. coli Competent Cells Sales Share by Manufacturers in 2023
 Figure 17. Global E. coli Competent Cells Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest E. coli Competent Cells Players: Market Share by Revenue in E. coli Competent Cells in 2023
 Figure 19. E. coli Competent Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global E. coli Competent Cells Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America E. coli Competent Cells Sales Market Share by Country (2019-2030)
 Figure 22. North America E. coli Competent Cells Revenue Market Share by Country (2019-2030)
 Figure 23. United States E. coli Competent Cells Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada E. coli Competent Cells Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe E. coli Competent Cells Sales Market Share by Country (2019-2030)
 Figure 26. Europe E. coli Competent Cells Revenue Market Share by Country (2019-2030)
 Figure 27. Germany E. coli Competent Cells Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France E. coli Competent Cells Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. E. coli Competent Cells Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy E. coli Competent Cells Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia E. coli Competent Cells Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific E. coli Competent Cells Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific E. coli Competent Cells Revenue Market Share by Region (2019-2030)
 Figure 34. China E. coli Competent Cells Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan E. coli Competent Cells Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea E. coli Competent Cells Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India E. coli Competent Cells Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia E. coli Competent Cells Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan E. coli Competent Cells Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia E. coli Competent Cells Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America E. coli Competent Cells Sales Market Share by Country (2019-2030)
 Figure 42. Mexico E. coli Competent Cells Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil E. coli Competent Cells Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina E. coli Competent Cells Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia E. coli Competent Cells Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa E. coli Competent Cells Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa E. coli Competent Cells Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey E. coli Competent Cells Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia E. coli Competent Cells Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE E. coli Competent Cells Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of E. coli Competent Cells by Type (2019-2030)
 Figure 52. Global Revenue Market Share of E. coli Competent Cells by Type (2019-2030)
 Figure 53. Global E. coli Competent Cells Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of E. coli Competent Cells by Application (2019-2030)
 Figure 55. Global Revenue Market Share of E. coli Competent Cells by Application (2019-2030)
 Figure 56. Global E. coli Competent Cells Price (US$/Unit) by Application (2019-2030)
 Figure 57. E. coli Competent Cells Value Chain
 Figure 58. E. coli Competent Cells Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network